SCHEMBL25994335

SCHEMBL25994335

CCNC[C@H]1C[C@H](OC)C1

nearest known ligand 0.38

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ SAT1 P21673 1/20 0.38
▸ TP53 P04637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24129485 1.00 SAT1 (0.38) SAT1TP53
SCHEMBL26050306 0.83 SAT1 (0.35) SAT1
SCHEMBL4224771 0.80 SAT1 (0.50) SAT1
SCHEMBL23482088 0.80 — —
SCHEMBL4224780 0.80 SAT1 (0.50) SAT1
SCHEMBL24842107 0.77 — —
SCHEMBL23029495 0.77 — —
SCHEMBL17113716 0.76 — —
SCHEMBL10034558 0.74 — —
SCHEMBL17778091 0.73 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3820573-B1 3-(5-HYDROXY-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF IKAROS FAMILY ZINC FINGER 2 (IKZF2)-DEPENDENT DISEASES NOVARTIS AG (CH) 2023-08-09 — — EP disclosed
Send feedback